We are live on
!
Find out more
OC
Oppenheimer & Co Portfolio holdings
AUM
$8.21B
1-Year Est. Return
28.81%
This Fund
S&P 500
This Quarter
Est. Return
+9.21%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$4.04B
AUM Growth
+$368M
(+10%)
Cap. Flow
+$68.3M
Cap. Flow
% of AUM
1.69%
Top 10 Holdings %
Top 10 Hldgs %
14.84%
Holding
1,360
New
108
Increased
584
Reduced
484
Closed
87
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DOCU
DocuSign
DOCU
|
+$4.67M |
| 2 |
Adobe
ADBE
|
+$4.33M |
| 3 |
Quanta Services
PWR
|
+$3.93M |
| 4 |
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
|
+$3.61M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$3.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$6.53M |
| 2 |
Apple
AAPL
|
+$5.68M |
| 3 |
iShares US Medical Devices ETF
IHI
|
+$4.6M |
| 4 |
iShares US Consumer Discretionary ETF
IYC
|
+$4.11M |
| 5 |
Constellation Brands
STZ
|
+$3.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.02% |
| 2 | Healthcare | 12.17% |
| 3 | Financials | 11.29% |
| 4 | Consumer Discretionary | 8.82% |
| 5 | Industrials | 8.29% |
Similar funds
LGF
CCM
CL
WJWM
CLOS
WA
CCM
KPWS
Oppenheimer & Co's Q4 2019 Portfolio in Review
As of Q4 2019, Oppenheimer & Co held 1,360 positions worth $4.04B, up 10% from $3.67B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Oppenheimer & Co's Q4 2019 filing shows 108 new, 584 increased, 484 reduced and 87 closed positions. Its largest new stake was CAE Inc. Common Shares: 78,310 shares worth $2.07M. The largest sale was Celgene Corp, an estimated $6.53M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.
- Oppenheimer & Co's largest Q4 2019 buy was CAE Inc. Common Shares: 78,310 shares worth $2.07M.
- Oppenheimer & Co added most to DocuSign in Q4 2019, an estimated $4.67M increase.
- Oppenheimer & Co's biggest Q4 2019 reduction was Apple, cutting an estimated $5.68M.
- Oppenheimer & Co fully exited Celgene Corp in Q4 2019, selling an estimated $6.53M.
- Oppenheimer & Co's ten largest holdings make up 15% of its $4.04B portfolio in Q4 2019.
- Oppenheimer & Co opened 108 new positions and closed 87 in Q4 2019.
- Oppenheimer & Co's portfolio value rose 10% quarter-over-quarter to $4.04B.
Based on Oppenheimer & Co's 13F filing for Q4 2019, filed 7 Feb 2020.